Abstract Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack…
Abstract Background: During the last two years, hexahydrocannabinol (HHC), the hydrogenated derivative of tetrahydrocannabinol has been freely sold by internet…
Abstract Background: Compelling evidence from preclinical and clinical studies supports the therapeutic role of cannabidiol (CBD) in several medical disorders.…
Abstract Simple Summary: We presented a comprehensive, systematic literature review of all published New Psychoactive Substances (NPS)-related intoxications and fatalities…
Abstract Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ9-tetrahydrocannabinol…
Abstract Synthetic cannabinoids (SCs) are a group of new psychoactive drugs used recreationally with potential health risks. They are monitored…
Abstract Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD…
Abstract Simple Summary: UR-144 is a synthetic cannabinoid found in herbal incenses for recreational use as a substitute of cannabis.…
Abstract Inhalation by vaporization is a useful application mode for medical cannabis. In this study, we present the disposition of…
Abstract The use of cannabis flowering tops with standardized amounts of active phytocannabinoids was recently authorized in several countries to…